Illumina Current Deferred Revenue vs Capital Surpluse Analysis
ILMN Stock | USD 111.35 0.73 0.66% |
Illumina financial indicator trend analysis is infinitely more than just investigating Illumina recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Illumina is a good investment. Please check the relationship between Illumina Current Deferred Revenue and its Capital Surpluse accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
Current Deferred Revenue vs Capital Surpluse
Current Deferred Revenue vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Illumina Current Deferred Revenue account and Capital Surpluse. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Illumina's Current Deferred Revenue and Capital Surpluse is 0.87. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Illumina, assuming nothing else is changed. The correlation between historical values of Illumina's Current Deferred Revenue and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Illumina are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Current Deferred Revenue i.e., Illumina's Current Deferred Revenue and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.87 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Capital Surpluse
Most indicators from Illumina's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Illumina current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.At this time, Illumina's Selling General Administrative is very stable compared to the past year. As of the 10th of May 2024, Enterprise Value Over EBITDA is likely to grow to 67.33, while Tax Provision is likely to drop about 41.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.2B | 3.0B | 2.7B | 2.9B | Total Revenue | 4.5B | 4.6B | 4.5B | 4.7B |
Illumina fundamental ratios Correlations
Click cells to compare fundamentals
Illumina Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Illumina fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.3B | 7.6B | 15.2B | 12.3B | 10.1B | 10.6B | |
Short Long Term Debt Total | 1.8B | 1.9B | 2.5B | 3.5B | 2.3B | 2.4B | |
Other Current Liab | 304M | 355M | 456M | 987M | 1.1B | 1.2B | |
Total Current Liabilities | 665M | 1.2B | 1.1B | 2.8B | 1.6B | 1.6B | |
Total Stockholder Equity | 4.6B | 4.7B | 10.7B | 6.6B | 5.7B | 6.0B | |
Property Plant And Equipment Net | 1.4B | 1.5B | 1.7B | 1.7B | 1.6B | 1.6B | |
Net Debt | (206M) | 45M | 1.2B | 1.5B | 1.2B | 1.3B | |
Retained Earnings | 4.1B | 4.7B | 5.5B | 1.1B | (19M) | (18.1M) | |
Accounts Payable | 149M | 192M | 332M | 293M | 245M | 257.3M | |
Cash | 2.0B | 1.8B | 1.2B | 2.0B | 1.0B | 673.0M | |
Non Current Assets Total | 2.9B | 3.1B | 12.5B | 8.7B | 7.5B | 7.9B | |
Non Currrent Assets Other | 105M | 171M | 445M | 423M | 217M | 123.4M | |
Cash And Short Term Investments | 3.4B | 3.5B | 1.3B | 2.0B | 1.1B | 1.2B | |
Net Receivables | 573M | 487M | 648M | 671M | 752M | 789.6M | |
Short Term Investments | 1.4B | 1.7B | 107M | 26M | 6M | 5.7M | |
Liabilities And Stockholders Equity | 7.3B | 7.6B | 15.2B | 12.3B | 10.1B | 10.6B | |
Non Current Liabilities Total | 2.0B | 1.6B | 3.4B | 2.9B | 2.8B | 2.9B | |
Other Current Assets | 105M | 152M | 295M | 285M | 216M | 226.8M | |
Other Stockholder Equity | 539M | (33M) | 5.2B | 5.5B | 5.8B | 6.1B | |
Total Liab | 2.7B | 2.9B | 4.5B | 5.7B | 4.4B | 4.6B | |
Total Current Assets | 4.5B | 4.5B | 2.7B | 3.6B | 2.6B | 1.8B | |
Short Term Debt | 45M | 511M | 71M | 1.2B | 86M | 81.7M | |
Intangible Assets | 145M | 142M | 3.3B | 3.3B | 3.0B | 3.1B | |
Other Liab | 202M | 303M | 915M | 649M | 746.4M | 783.7M | |
Current Deferred Revenue | 167M | 186M | 234M | 245M | 252M | 264.6M | |
Other Assets | 179M | 609M | 445M | 212M | 243.8M | 133.6M | |
Long Term Debt | 1.1B | 673M | 1.7B | 1.5B | 1.5B | 769.5M | |
Inventory | 359M | 372M | 431M | 568M | 587M | 616.4M | |
Property Plant And Equipment Gross | 1.4B | 1.5B | 1.7B | 1.7B | 2.7B | 2.8B | |
Property Plant Equipment | 889M | 922M | 1.7B | 1.1B | 1.3B | 1.3B | |
Good Will | 824M | 897M | 7.1B | 3.2B | 2.5B | 2.7B | |
Treasury Stock | (2.6B) | (3.0B) | (3.8B) | (3.7B) | (3.3B) | (3.2B) | |
Net Tangible Assets | 4.3B | 4.3B | 377M | 4.1B | 4.7B | 4.9B | |
Retained Earnings Total Equity | 4.1B | 4.7B | 5.5B | 1.1B | 1.3B | 2.0B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Illumina Stock analysis
When running Illumina's price analysis, check to measure Illumina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Illumina is operating at the current time. Most of Illumina's value examination focuses on studying past and present price action to predict the probability of Illumina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Illumina's price. Additionally, you may evaluate how the addition of Illumina to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Illumina's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (8.15) | Revenue Per Share 28.392 | Quarterly Revenue Growth (0.01) | Return On Assets (0.01) |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.